Circulating Antimicrobial Peptide LL-37 Status in Type 1 Diabetes Mellitus and its Relation with Glycemic Control
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Circulating Antimicrobial Peptide LL-37 Status in Type 1 Diabetes Mellitus and its Relation with Glycemic Control ; volume:53 ; number:02 ; year:2017 ; pages:066-072
Annals of National Academy of Medical Sciences (India) ; 53, Heft 02 (2017), 066-072
- Contributor
-
Chawla, Himika
Kar, Parmita
Saha, Soma
Singh, Urvashi B.
Tandon, Nikhil
R., Goswami
- DOI
-
10.1055/s-0040-1712747
- URN
-
urn:nbn:de:101:1-2020070908365095502638
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:52 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Chawla, Himika
- Kar, Parmita
- Saha, Soma
- Singh, Urvashi B.
- Tandon, Nikhil
- R., Goswami
Other Objects (12)
Positive correlation between circulating cathelicidin antimicrobial peptide (hCAP18/LL-37) and 25-hydroxyvitamin D levels in healthy adults
Proteomic Adaptation of Streptococcus pneumoniae to the Human Antimicrobial Peptide LL-37
Recombinant production of human antimicrobial peptide LL- 37 and its secondary structure
The impact of cathelicidin, the human antimicrobial peptide LL-37 in urinary tract infections
HIF-1 mediated activation of antimicrobial peptide LL-37 in type 2 diabetic patients
The impact of N-glycosylation on the properties of the antimicrobial peptide LL-III
Remodeling of the Fibrillation Pathway of α‐Synuclein by Interaction with Antimicrobial Peptide LL‐III
Remodeling of the fibrillation pathway of α-synuclein by interaction with antimicrobial peptide LL-III
LL-37_Renalexin hybrid peptide exhibits antimicrobial activity at lower MICs than its counterpart single peptides
The antimicrobial effect of a novel peptide LL-1 on Escherichia coli by increasing membrane permeability
Activation of Eosinophils Interacting with Bronchial Epithelial Cells by Antimicrobial Peptide LL-37: Implications in Allergic Asthma
A stable cyclized antimicrobial peptide derived from LL-37 with host immunomodulatory effects and activity against uropathogens
Positive correlation between circulating cathelicidin antimicrobial peptide (hCAP18/LL-37) and 25-hydroxyvitamin D levels in healthy adults
Proteomic Adaptation of Streptococcus pneumoniae to the Human Antimicrobial Peptide LL-37
Recombinant production of human antimicrobial peptide LL- 37 and its secondary structure
The impact of cathelicidin, the human antimicrobial peptide LL-37 in urinary tract infections
HIF-1 mediated activation of antimicrobial peptide LL-37 in type 2 diabetic patients
The impact of N-glycosylation on the properties of the antimicrobial peptide LL-III
Remodeling of the Fibrillation Pathway of α‐Synuclein by Interaction with Antimicrobial Peptide LL‐III
Remodeling of the fibrillation pathway of α-synuclein by interaction with antimicrobial peptide LL-III
LL-37_Renalexin hybrid peptide exhibits antimicrobial activity at lower MICs than its counterpart single peptides
The antimicrobial effect of a novel peptide LL-1 on Escherichia coli by increasing membrane permeability
Activation of Eosinophils Interacting with Bronchial Epithelial Cells by Antimicrobial Peptide LL-37: Implications in Allergic Asthma
A stable cyclized antimicrobial peptide derived from LL-37 with host immunomodulatory effects and activity against uropathogens
Positive correlation between circulating cathelicidin antimicrobial peptide (hCAP18/LL-37) and 25-hydroxyvitamin D levels in healthy adults
Proteomic Adaptation of Streptococcus pneumoniae to the Human Antimicrobial Peptide LL-37
Recombinant production of human antimicrobial peptide LL- 37 and its secondary structure
The impact of cathelicidin, the human antimicrobial peptide LL-37 in urinary tract infections
HIF-1 mediated activation of antimicrobial peptide LL-37 in type 2 diabetic patients
The impact of N-glycosylation on the properties of the antimicrobial peptide LL-III
Remodeling of the Fibrillation Pathway of α‐Synuclein by Interaction with Antimicrobial Peptide LL‐III
Remodeling of the fibrillation pathway of α-synuclein by interaction with antimicrobial peptide LL-III
LL-37_Renalexin hybrid peptide exhibits antimicrobial activity at lower MICs than its counterpart single peptides
The antimicrobial effect of a novel peptide LL-1 on Escherichia coli by increasing membrane permeability
Activation of Eosinophils Interacting with Bronchial Epithelial Cells by Antimicrobial Peptide LL-37: Implications in Allergic Asthma